intismeran autogene

AssetAlso V940, mRNA-4157

Encodes individualized tumor neoantigens to stimulate tumor-specific T-cell immune responses.

Stage
Human trials
Modality
mRNA
Target
Not known
2
Indications
0
Trials
1
Developer

Indications

2

In the full profile

  • Owner and partners2
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets